New SEC Form D filing

Grace Therapeutics, Inc., 2026-08-11

A new SEC Form D private-offering notice from Princeton, NJ, a $9,999,998 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Grace Therapeutics, Inc. site↗ Verified via SEC Form D

Late-stage biopharma company developing drug candidates for rare and orphan diseases, lead program GTx-104 for aneurysmal subarachnoid hemorrhage

Filed 2026-08-11Filed to raise $9,999,998First money in 2026-08-04Raised so far $9,999,998HQ (as filed) Princeton, NJSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified gracetx.com↗Named in the filing 8 executives & directors
Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source